Orphan Drugs and Rare Diseases Europe 2017 is focused on orphan drugs and includes the following topics:
- Pricing and Reimbursement
- Market Access
- Patient Engagement and Recruitment
- Regulatory Requirements
Orphan Drugs and Rare Diseases Europe 2017 is intended for:
- Researchers and regulators
- Patient advocacy organisations
- Pharmaceutical companies
- Small biotechs